Drugs / Human urinary kininogenase
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT06696703 | Jan 2024 → Dec 2025 overdue | ischemic stroke | First Affiliated Hospital of Harbin Medical University | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Human urinary kininogenase | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06696703 ↗ |
| Known as | HUK | “Human urinary kininogenase(HUK)” NCT06696703 ↗ |
| Route | Intravenous | “by intravenous infusion for not less than 50 minutes” NCT06696703 ↗ |